Menu

Deep Pocket Exploration

A modification to traditional docking software enables the examination of a ligand’s passage into its receptor.

Feb 1, 2017
Ruth Williams

MOLECULAR SPELUNKING: AutoDock Vina evaluates a receptor’s entire binding pocket at once to find a docking site (lowest-energy binding) for a ligand of interest. The deepest part of the pocket (the actual binding site for auxin shown at the bottom of (1) naturally has a low energy requirement, and this is where, in the case of tryptophan (2), the software suggests a docking site. But by forcing the software to move in incremental steps—starting at the mouth of the pocket and moving inward—TomoDock finds an interaction of tryptophan with residues farther up the pocket (3) that prevents deeper entry. In the case of auxin, however, TomoDock finds the same binding site as that found using AutoDock Vina (step-wise progress of TomoDock shown in (1).© GEORGE RETSECK

Auxins are a family of small-molecule hormones that control growth and development processes in plants. They are also components of widely used herbicides. In a drive to extend the agricultural and horticultural applications of these hormones, scientists are attempting to design new synthetic auxins. But to do so, they must understand the nitty-gritty of how an auxin molecule binds to it receptor, says Richard Napier of the University of Warwick in the U.K.

Napier’s team uses docking software to simulate auxin binding. But there’s a problem: the software also allows molecules to dock that, Napier says, are known not to bind in reality—such as auxin’s close relative tryptophan. “Getting false positives out of docking [analyses] is absolutely part of the deal,” he says. “Docking is not a perfect science.”

To reduce such permissiveness, Napier and his colleagues have written additional computational code for a popular docking program, AutoDock Vina. For receptors with deep binding-site pockets (like that of the auxin receptor), the new code mimics the molecule’s natural passage by searching for the docking site in a sequence of 0.1-nanometer steps.

Drawing an analogy with a cave, Ning Zheng of the University of Washington says, “The conventional [docking] method just looks at whether a child or adult can be accommodated by the cave interior, but if that cave is separated from the outside by, let’s say, a narrow cleft, then . . . maybe it turns out the adult is too big to pass [through].”

Restriction of a molecule’s access may not be due to size, but to interactions with residues on the “cave” walls as it enters—which is the case for tryptophan, Napier’s team has now discovered. Without simulating a molecule’s passage, as per the new method, called TomoDock, such interactions can be missed, Napier says. (Open Biology, 6:160139, 2016) 

DOCKING PROGRAM BINDING SITE EVALUATION
 
APPLICABILITY ACCESS
AutoDock Vina A 3-D cuboidal area encompassing the entire binding pocket of a receptor All ligand-receptor interactions Free to download from vina.scripps.edu
TomoDock (with AutoDock Vina) A 3-D cuboidal area big enough to encompass the entire binding pocket, but which is initially positioned at the mouth of the binding pocket and then moved stepwise into the pocket in small increments Specifically for receptors with deep binding pockets or transport proteins in which molecules of interest pass though a channel Free to download from www2.warwick.ac.uk/fac/cross_fac/
complexity/people/staff/delgenio/tomocode

 

September 2018

The Muscle Issue

The dynamic tissue reveals its secrets

Marketplace

Sponsored Product Updates

Enabling Genomics-Guided Precision Medicine

Enabling Genomics-Guided Precision Medicine

Download this eBook from Qiagen to learn more about the promise of precision medicine and how QCITM Interpret can help deliver better care with better knowledge.

Best Practices for Sample Preparation and Lipid Extraction from Various Samples

Best Practices for Sample Preparation and Lipid Extraction from Various Samples

Download this white paper from Bertin Technologies to learn how to extract and analyze lipid samples from various models!

Bio-Rad Launches CHT Ceramic Hydroxyapatite XT Media and Nuvia HP-Q Resin for Process Protein Purification

Bio-Rad Launches CHT Ceramic Hydroxyapatite XT Media and Nuvia HP-Q Resin for Process Protein Purification

Bio-Rad Laboratories, Inc. (NYSE: BIO and BIOb), a global leader of life science research and clinical diagnostic products, today announced the launch of two new chromatography media for process protein purification: CHT Ceramic Hydroxyapatite XT Media and Nuvia HP-Q Resin.

Immunophenotypic Analysis of Human Blood Leukocyte Subsets

Immunophenotypic Analysis of Human Blood Leukocyte Subsets

Download this application note from ACEA Biosciences, Inc., to find out how to perform an immunophenotypic analysis of a human blood sample utilizing 13 fluorescent markers using a compact benchtop flow cytometer equipped with 3 lasers!